ARUP's Laboratory Test Directory

Inflammatory Bowel Disease Differentiation Profile : 0050567

Mnemonic: IBD

Methodology: Enzyme-Linked Immunosorbent Assay/Indirect Fluorescent Antibody
Performed: Refer to individual components
Reported: Refer to individual components
Specimen Required: Collect:  One 4 mL serum separator tube.

Transport:  1.5 mL serum at 2-8°C. (Min: 1 mL)  Submit specimen in an ARUP Standard Transport Tube.

Pediatric Collection/Transport:  0.5 mL serum at 2-8°C.

Remarks:  Separate serum from cells ASAP.

Unacceptable Conditions:  Severely lipemic, contaminated, heat-inactivated, or hemolyzed specimens.

Stability:  After separation from cells: Ambient: 2 days; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Reference Interval:
 
Available Separately Components Reference Interval
 Saccharomyces cerevisiae Antibody, IgG  £ 20 Units: No Antibody Detected
21-24 Units: Equivocal
³ 25 Units: Positive
 Saccharomyces cerevisiae Antibody, IgA £ 20 Units: No Antibody Detected
21-24 Units: Equivocal
³ 25 Units: Positive
 Anti-Neutrophil Cytoplasmic Antibody, Atypical Pattern < 1:20:  Not significant
 

Interpretive Data: P-ANCA antibodies are found in 50-70% of ulcerative colitis (UC) patients, but in only 20% of Crohn disease (CD) patients.  In contrast, Saccharomyces cerevisiae IgG antibodies are found in 80% of CD patients, but only 20% of UC patients.  Saccharomyces cerevisiae IgA antibodies are found in 35% of CD patients but < 1% in UC patients.
Note: This test may be a useful tool for distinguishing ulcerative colitis (UC) from Crohn disease (CD) in patients with suspected inflammatory bowel disease.
CPT Code(s): 86671 x2 Semiquantitative immunoassay-fungus not elsewhere specified; 86255 Fluorescent noninfectious agent antibody screen
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org